Factors affecting screening for hepatocellular carcinoma

Farah Al Hasani, Marina Knoepfli, Armin Gemperli, Attila Kollar, Vanessa Banz, Joachim Kettenbach, Peter Jüni, Jean-François Dufour
Annals of Hepatology  
Hepatocellular carcinoma (HCC) is a frequent cancer. Its prognosis is highly dependent on early diagnosis. Patients at risk for developing HCC should be enrolled in a surveillance programme. Nevertheless, many patients at risk are not regularly screened. We aimed at exploring the characteristics that affect enrolment in a surveillance programme. The characteristics of the patients included in the prospective Bern HCC cohort between August 2010 and August 2011 were analysed according to their
more » ... ticipation in a surveillance programme. Among the 82 patients included in the cohort during this period of time, 48 were in a surveillance program before the diagnosis of HCC. Thirty five percent of cirrhotic patients were not screened. Age, sex, level of education, Child-Pugh status and MELD score were similar between the patients who were screened and those who were not screened. Patients with a private insurance and patients treated by a liver specialist were more frequently enrolled in a surveillance program. Sixty seven percent of the screened patients were eligible for curative treatment whereas only 15% of the non-screened patients were. In conclusion the surveillance of patients at risk for developing HCC increases their chances to be diagnosed at an early stage to allow curative treatment. More than one third of cirrhotic patients were not regularly screened. Patients with chronic liver disease should be referred to identify those at risk and enrol them in a surveillance program.
pmid:24552862 fatcat:o34gvtfoqvbzza3zrcnp2jbjzy